Status:
COMPLETED
Incidence of Residual Tricuspid Regurgitation in Patients Undergoing Left-heart Surgery
Lead Sponsor:
Mahidol University
Conditions:
Residual Tricuspid Regurgitation
Left-sided Cardiac Surgery
Eligibility:
All Genders
18+ years
Brief Summary
Functional tricuspid valve regurgitation is commonly co-existed with left-sided cardiac lesion, especially mitral valve stenosis. Both lesion were recommended to surgically fixed at the same setting. ...
Detailed Description
Functional tricuspid regurgitation (TR) was defined as TR occurring secondary to left heart, especially mitral valve stenosis or pulmonary disease. Previous study reported that about 30% - 50% of pati...
Eligibility Criteria
Inclusion
- Mitral valve or aortic valve diseases requiring surgical intervention
- No pathologic changes in TV leaflets
- No previous tricuspid valve surgery
Exclusion
- Patients with incomplete data
- Patient with history of previous cardiac surgery
- Patient with congenital anomalies of mitral or tricuspid valve
- Patient with both tricuspid stenosis and regurgitation
Key Trial Info
Start Date :
November 20 2020
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
April 30 2022
Estimated Enrollment :
275 Patients enrolled
Trial Details
Trial ID
NCT04414358
Start Date
November 20 2020
End Date
April 30 2022
Last Update
May 13 2022
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Faculty of Medicine Siriraj Hospital
Bangkok, Thailand, 10700